Showing results (1131-1140 of 1,167) with videos related to
Sort By:
Pageof 117
Nature Communications|April 26, 2024
Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genesZhishan Chen, Xingyi Guo, Ran Tao, et al.Nature Genetics|April 25, 2017
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer riskFelix R Day, Deborah J Thompson, Hannes Helgason, et al.American Journal of Human Genetics|December 23, 2014
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1Dylan M Glubb, Mel J Maranian, Kyriaki Michailidou, et al.Human Molecular Genetics|February 6, 2015
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2Nick Orr, Frank Dudbridge, Nicola Dryden, et al.Nature Communications|April 17, 2019
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancerManuel A Ferreira, Eric R Gamazon, Fares Al-Ejeh, et al.Nature Genetics|June 20, 2018
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancerLang Wu, Wei Shi, Jirong Long, et al.Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Understanding the genetic complexity of puberty timing across the allele frequency spectrumKatherine A Kentistou, Lena R Kaisinger, Stasa Stankovic, et al.Cancer Discovery|July 20, 2016
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesSiddhartha P Kar, Jonathan Beesley, Ali Amin Al Olama, et al.Nature Genetics|July 1, 2024
Understanding the genetic complexity of puberty timing across the allele frequency spectrumKatherine A Kentistou, Lena R Kaisinger, Stasa Stankovic, et al.Nature Communications|February 18, 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.Pageof 117